📰 Formulation Development News
Formulation Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Formulation Development. Real-time updates on events, politics, business and more.
July 7, 2024
Publicprivate partnership. This is 90 minutes. The subcommittee on space and aeronautics will come to order. Without objection the chair is authorized to declare recess on at any time. Welcome to todays hearing entitled returning to the moon, keeping artemis on track. I would like to acknowledge i appreciate the witnesses being here today. Mother nature is proving to be somewhat challenging this week as you can see by the turnout of membership. This has been hearing thats been much anticipated b...
June 30, 2024
Back to gadgets . We will be live this hour. Betty a jampacked day today. You cannot get the bond kings to not talk today. This is noting that the 10 year, seemseasury bull market to become to an end and the bear market is starting with a yield and hitting 2. 5 and then you have jeffrey, coming out of the later, also in his outlook and webcast when he talks about bill gross saying that this might be a little early but with these yields rising, it is going to hurt u. S. Equities, he noted that ev...
June 21, 2024
Sure its very important. That we have the appropriate people working. Im a big supporter of igs, and we take it seriously. We have implemented their recommendations. We have a personal Security Group now that ensures before an offer goes out if you have violated 1203b which are the two most serious issues you dont get hired. And if there are other conduct issues, not only are we going to follow the opm rules were going to review those for appropriateness for employment at the irs. People need to...
April 22, 2024
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual...
March 25, 2024
Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat...
February 19, 2024
/PRNewswire/ -- The "Viral Vectors and Plasmid DNA Global Market Report 2024" has been added to ResearchAndMarkets.coms offering. Substantial Growth...
January 16, 2024
/PRNewswire/ -- The pharmaceutical contract research and manufacturing (CRAM) market is expected to grow by USD 121.35 billion from 2022 to 2027. In addition,...
December 11, 2023
/PRNewswire/ -- Maridose, a leading DEA licensed manufacturer specializing in cannabis-based products, proudly announces the launch of their groundbreaking...
December 4, 2023
Boyds grows regulatory affairs team with new hire Boyds, the global drug development consultancy, has appointed Monica Pianella as Associate Director of Regulatory Affairs. With over seven years’ experience in advanced therapies, Monica joins Boyds from the Cell and Gene Therapy Catapult (CGTC) where...
November 20, 2023
Rising focus on cost-effective manufacturing and growing consumer demand for naturally sourced ingredients in products will drive Cosmetic CDMO Market...